Eggenstein-Leopoldshafen, Germany

Pavel A Levkin

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 2.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Pavel A Levkin: Innovator in Dendrimeric Substrates and Amino Lipids

Introduction

Pavel A Levkin is a notable inventor based in Eggenstein-Leopoldshafen, Germany. He has made significant contributions to the fields of chemical synthesis and biotechnology, holding 2 patents that showcase his innovative spirit and technical expertise.

Latest Patents

Levkin's latest patents include "Patterned, dendrimeric substrate surfaces and production and use thereof." This invention relates to a patterned substrate that comprises first regions with first dendrimer structures and second regions with second dendrimer structures. The substrate is designed for various applications, including chemical synthesis and cell treatment. His second patent, "Amino lipids, their synthesis and uses thereof," introduces new amino lipids and a convenient method for synthesizing these compounds. These cationic amino lipids serve as effective transfection agents, and the invention also covers lipid particles containing these amino lipids for delivering bioactive agents into cells.

Career Highlights

Throughout his career, Levkin has worked with prominent organizations such as Incella GmbH and the Karlsruhe Institute of Technology. His work in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in his field.

Collaborations

Levkin has collaborated with notable individuals, including Gary Davidson and Linxian Li. These partnerships have likely enriched his research and development efforts, fostering a collaborative environment for innovation.

Conclusion

Pavel A Levkin stands out as a significant figure in the realm of innovations related to dendrimeric substrates and amino lipids. His patents reflect a commitment to advancing technology and improving methodologies in chemical synthesis and biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…